Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Sales | 0 | 68 | 0 | 1,000 | 346 |
Cost of Goods | N/A | 100 | N/A | 350 | N/A |
Gross Profit | N/A | -32 | N/A | 650 | 346 |
Operating Expenses | 12,038 | 13,004 | 9,380 | 9,008 | 20,937 |
Operating Income | -12,038 | -12,936 | -9,380 | -8,008 | -20,591 |
Interest Expense | 101 | 178 | 157 | 200 | 201 |
Other Income | 3,032 | 5,993 | 3,103 | 4,111 | -1,252 |
Pre-tax Income | -9,107 | -7,121 | -6,434 | -4,097 | -22,044 |
Net Income Continuous | -9,107 | -7,121 | -6,434 | -4,097 | -22,044 |
Net Income | $-9,107 | $-7,121 | $-6,434 | $-4,097 | $-22,044 |
EPS Basic Total Ops | -0.54 | 0.63 | -1.00 | -1.36 | -3.80 |
EPS Basic Continuous Ops | -0.54 | 0.46 | -1.00 | -0.71 | -3.80 |
EPS Diluted Total Ops | -0.54 | 0.63 | -1.00 | -1.36 | -3.80 |
EPS Diluted Continuous Ops | -0.54 | 0.46 | -1.00 | -0.71 | -3.80 |
EPS Diluted Before Non-Recurring Items | -0.54 | N/A | -1.48 | N/A | N/A |
EBITDA(a) | $-11,150 | $-11,927 | $-8,295 | $-6,638 | $-19,478 |